Yabao Pharmaceutical Group Co Ltd (600351) — Cash Flow Quality Index
Yabao Pharmaceutical Group Co Ltd (600351) has a Cash Flow Quality Index of 3.18x as of September 2025. Operating cash flow of CN¥129.49 Million exceeds net income of CN¥40.70 Million, indicating high earnings quality where cash backs reported profits. Explore Yabao Pharmaceutical Group Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yabao Pharmaceutical Group Co Ltd Cash Flow Quality Index (2001–2024)
Historical Cash Flow Quality Index for Yabao Pharmaceutical Group Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600351 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Yabao Pharmaceutical Group Co Ltd (2001–2024)
Year-by-year earnings quality comparison for Yabao Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see how much is Yabao Pharmaceutical Group Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.11x | CN¥471.69 Million | CN¥223.92 Million | ▼ -15.5% |
| 2023 | 2.49x | CN¥497.55 Million | CN¥199.59 Million | ▼ -43.4% |
| 2022 | 4.40x | CN¥460.46 Million | CN¥104.60 Million | ▲ +84.9% |
| 2021 | 2.38x | CN¥437.50 Million | CN¥183.76 Million | ▼ -31.9% |
| 2020 | 3.50x | CN¥380.96 Million | CN¥108.99 Million | ▼ -91.1% |
| 2019 | 39.37x | CN¥425.17 Million | CN¥10.80 Million | ▲ +2521.3% |
| 2018 | 1.50x | CN¥426.60 Million | CN¥284.02 Million | ▲ +85.6% |
| 2017 | 0.81x | CN¥161.73 Million | CN¥199.82 Million | ▼ -86.0% |
| 2016 | 5.77x | CN¥155.95 Million | CN¥27.04 Million | ▲ +776.6% |
| 2015 | 0.66x | CN¥143.47 Million | CN¥218.05 Million | ▼ -39.2% |
| 2014 | 1.08x | CN¥178.63 Million | CN¥165.11 Million | ▲ +115.7% |
| 2013 | 0.50x | CN¥56.80 Million | CN¥113.26 Million | ▲ +157.0% |
| 2012 | -0.88x | CN¥-96.73 Million | CN¥109.87 Million | ▼ -526.8% |
| 2011 | 0.21x | CN¥40.73 Million | CN¥197.41 Million | ▲ +54.9% |
| 2010 | 0.13x | CN¥18.57 Million | CN¥139.40 Million | ▼ -95.4% |
| 2009 | 2.88x | CN¥368.56 Million | CN¥128.16 Million | ▲ +142.5% |
| 2008 | 1.19x | CN¥102.90 Million | CN¥86.76 Million | ▼ -46.2% |
| 2007 | 2.20x | CN¥105.69 Million | CN¥47.95 Million | ▲ +169.6% |
| 2006 | 0.82x | CN¥11.59 Million | CN¥14.18 Million | ▼ -47.7% |
| 2005 | 1.56x | CN¥26.40 Million | CN¥16.88 Million | ▼ -34.0% |
| 2004 | 2.37x | CN¥79.73 Million | CN¥33.63 Million | ▲ +708.2% |
| 2003 | -0.39x | CN¥-9.62 Million | CN¥24.68 Million | ▼ -132.0% |
| 2002 | 1.22x | CN¥24.29 Million | CN¥19.94 Million | ▼ -5.7% |
| 2001 | 1.29x | CN¥23.59 Million | CN¥18.26 Million | — |